House Passes FDA Amendments Bill
The House passed the Food and Drug Amendments of 2022 on June 8 on a 392-28 vote. The bill, which addresses user fees for drugs, generic drugs, biosimilars and devices, also includes provisions on FDA inspections of drug and device…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
facilities. Among other things, it would provide in law for an FDA pilot program on unannounced foreign facility inspections. FDA has said it will begin such a pilot for facilities in China and India in 2022 (see 2202090025).